Sector:
Life Science
Biotech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
About
Courage Therapeutics is a pre-clinical stage biopharmaceutical company focused on providing patients with new modalities for treating obesity and diseases of wasting. Helmed by CEO Giovanni Ferrara, the company brings together an experienced team of scientists and industry experts focusing on developing scientific discoveries regarding the brain’s response to energy signals from the body. Founder Dr. Roger Cone, the Mary Sue Coleman Director of the Life Sciences Institute and the Vice Provost for the Biosciences Initiative at the University of Michigan, spearheaded the company’s licensing agreement with the University to develop treatments based on a portfolio of intellectual property jointly invented with Courage. The Courage medicinal chemistry team has pending patents on multiple compounds with highly selective and potent MC3R and MC4R activity.
YouTube
Team
